Categories AlphaGraphs, Cannabis, Earnings
HEXO Earnings: Highlights of Hexo’s Q2 2022 financial results
Cannabis producer HEXO Corp. (NASDAQ: HEXO) has reported a wider net loss for the second quarter of 2022. However, the Canada-based company’s revenues increased 61% during the three-month period.
Net loss and comprehensive loss widened to C$690.3 million in the January quarter from C$20.8 million in the prior-year period.
At C$52.8 million, net revenues were up 61% year-over-year, reflecting double-digit growth in the adult-use and medical cannabis segments. International cannabis revenues more than doubled.
Read management/analysts’ comments on quarterly reports
The value of Hexo shares more than halved in the past six months at the Nasdaq stock exchange and slipped below one dollar. The stock traded lower in early trading on Tuesday.
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
